HCSG: Healthcare Services Group Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Healthcare Services Group Inc (HCSG).

OverviewDividends

$851.28M Market Cap.

As of 02/18/2025 5:00 PM ET (MRY) • Disclaimer

HCSG Market Cap. (MRY)


HCSG Shares Outstanding (MRY)


HCSG Assets (MRY)


Total Assets

$802.77M

Total Liabilities

$302.85M

Total Investments

$168.12M

HCSG Income (MRY)


Revenue

$1.72B

Net Income

$39.47M

Operating Expense

$183.06M

HCSG Cash Flow (MRY)


CF Operations

$30.80M

CF Investing

$6.05M

CF Financing

-$31.05M

HCSG Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$802,772,000 (1.53%)

$790,652,000 (10.07%)

$718,334,000 (-7.61%)

$777,529,000 (-0.96%)

Assets Current

$556,652,000 (-2.63%)

$571,696,000 (12.40%)

$508,632,000 (-6.91%)

$546,382,000 (-4.55%)

Assets Non-Current

$246,120,000 (12.41%)

$218,956,000 (4.41%)

$209,702,000 (-9.28%)

$231,147,000 (8.71%)

Goodwill & Intangible Assets

$84,971,000 (-3.06%)

$87,656,000 (-4.17%)

$91,475,000 (-4.27%)

$95,560,000 (37.95%)

Shareholders Equity

$499,927,000 (9.49%)

$456,616,000 (7.14%)

$426,172,000 (-5.86%)

$452,677,000 (-5.78%)

Property Plant & Equipment Net

$28,198,000 (-2.00%)

$28,774,000 (25.24%)

$22,975,000 (-18.24%)

$28,102,000 (5.80%)

Cash & Equivalents

$60,131,000 (10.68%)

$54,330,000 (106.74%)

$26,279,000 (-62.88%)

$70,794,000 (-49.19%)

Accumulated Other Comprehensive Income

-$2,317,000 (-25.65%)

-$1,844,000 (46.97%)

-$3,477,000 (-186.93%)

$4,000,000 (-28.10%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$168,123,000 (42.52%)

$117,963,000 (-7.70%)

$127,809,000 (-11.03%)

$143,655,000 (-9.89%)

Investments Current

$127,069,000 (36.44%)

$93,131,000 (-2.17%)

$95,200,000 (-16.78%)

$114,396,000 (-8.49%)

Investments Non-Current

$41,054,000 (65.33%)

$24,832,000 (-23.85%)

$32,609,000 (11.45%)

$29,259,000 (-14.99%)

Inventory

$16,749,000 (-9.36%)

$18,479,000 (-12.69%)

$21,164,000 (-18.65%)

$26,015,000 (-17.64%)

Trade & Non-Trade Receivables

$330,907,000 (-13.72%)

$383,509,000 (13.88%)

$336,777,000 (14.79%)

$293,388,000 (14.84%)

Trade & Non-Trade Payables

$81,147,000 (-2.50%)

$83,224,000 (21.86%)

$68,296,000 (6.02%)

$64,419,000 (23.32%)

Accumulated Retained Earnings (Deficit)

$224,556,000 (21.38%)

$185,010,000 (19.75%)

$154,495,000 (-16.02%)

$183,957,000 (-8.43%)

Tax Assets

$38,170,000 (8.36%)

$35,226,000 (0.74%)

$34,967,000 (-13.34%)

$40,348,000 (12.24%)

Tax Liabilities

$8,391,000 (16.53%)

$7,201,000 (0%)

$0 (0%)

$0 (0%)

Total Debt

$8,033,000 (-77.83%)

$36,235,000 (9.48%)

$33,097,000 (192.92%)

$11,299,000 (-0.56%)

Debt Current

$0 (0%)

$25,000,000 (0.00%)

$25,000,000 (0%)

$0 (0%)

Debt Non-Current

$8,033,000 (-28.50%)

$11,235,000 (38.76%)

$8,097,000 (-28.34%)

$11,299,000 (-0.56%)

Total Liabilities

$302,845,000 (-9.34%)

$334,036,000 (14.33%)

$292,162,000 (-10.06%)

$324,852,000 (6.66%)

Liabilities Current

$192,547,000 (-11.24%)

$216,928,000 (21.45%)

$178,619,000 (-6.54%)

$191,125,000 (17.79%)

Liabilities Non-Current

$110,298,000 (-5.82%)

$117,108,000 (3.14%)

$113,543,000 (-15.09%)

$133,727,000 (-6.03%)

HCSG Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,715,682,000 (2.65%)

$1,671,389,000 (-1.11%)

$1,690,176,000 (2.94%)

$1,641,959,000 (-6.72%)

Cost of Revenue

$1,487,592,000 (2.12%)

$1,456,643,000 (-2.65%)

$1,496,336,000 (5.74%)

$1,415,082,000 (-5.18%)

Selling General & Administrative Expense

$183,060,000 (9.77%)

$166,772,000 (18.83%)

$140,344,000 (-18.93%)

$173,108,000 (14.81%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$183,060,000 (9.77%)

$166,772,000 (18.83%)

$140,344,000 (-18.93%)

$173,108,000 (14.81%)

Interest Expense

$6,438,000 (-18.05%)

$7,856,000 (163.01%)

$2,987,000 (115.67%)

$1,385,000 (0.80%)

Income Tax Expense

$13,470,000 (-8.18%)

$14,670,000 (40.36%)

$10,452,000 (-34.51%)

$15,960,000 (-47.68%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$39,471,000 (2.83%)

$38,386,000 (10.85%)

$34,630,000 (-24.49%)

$45,863,000 (-53.52%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$39,471,000 (2.83%)

$38,386,000 (10.85%)

$34,630,000 (-24.49%)

$45,863,000 (-53.52%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$39,471,000 (2.83%)

$38,386,000 (10.85%)

$34,630,000 (-24.49%)

$45,863,000 (-53.52%)

Weighted Average Shares

$73,754,000 (-0.72%)

$74,288,000 (-0.06%)

$74,336,000 (-0.64%)

$74,816,000 (0.16%)

Weighted Average Shares Diluted

$73,988,000 (-0.47%)

$74,340,000 (-0.01%)

$74,351,000 (-0.82%)

$74,962,000 (0.24%)

Earning Before Interest & Taxes (EBIT)

$59,379,000 (-2.52%)

$60,912,000 (26.72%)

$48,069,000 (-23.95%)

$63,208,000 (-51.59%)

Gross Profit

$228,090,000 (6.21%)

$214,746,000 (10.79%)

$193,840,000 (-14.56%)

$226,877,000 (-15.34%)

Operating Income

$45,030,000 (-6.14%)

$47,974,000 (-10.32%)

$53,496,000 (-0.51%)

$53,769,000 (-54.13%)

HCSG Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$6,047,000 (283.63%)

-$3,293,000 (-227.64%)

$2,580,000 (111.22%)

-$22,990,000 (37.60%)

Net Cash Flow from Financing

-$31,048,000 (-155.45%)

-$12,154,000 (68.78%)

-$38,928,000 (52.90%)

-$82,654,000 (-20.90%)

Net Cash Flow from Operations

$30,802,000 (-29.19%)

$43,498,000 (632.61%)

-$8,167,000 (-122.01%)

$37,108,000 (-82.92%)

Net Cash Flow / Change in Cash & Cash Equivalents

$5,801,000 (-79.32%)

$28,051,000 (163.01%)

-$44,515,000 (35.05%)

-$68,536,000 (-161.19%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$114,000 (99.52%)

-$23,876,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$12,172,000 (511.04%)

$1,992,000 (-73.48%)

$7,511,000 (18.06%)

$6,362,000 (119.41%)

Capital Expenditure

-$6,125,000 (-15.89%)

-$5,285,000 (-9.72%)

-$4,817,000 (12.03%)

-$5,476,000 (-34.64%)

Issuance (Repayment) of Debt Securities

-$25,000,000 (0%)

$0 (0%)

$25,000,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

-$5,018,000 (55.53%)

-$11,283,000 (-2286.63%)

$516,000 (102.71%)

-$19,018,000 (-731.20%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

-$63,373,000 (-1.84%)

-$62,226,000 (-2.51%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$9,165,000 (2.00%)

$8,985,000 (-2.49%)

$9,214,000 (4.38%)

$8,827,000 (12.13%)

Depreciation Amortization & Accretion

$14,585,000 (1.68%)

$14,344,000 (-6.35%)

$15,316,000 (4.42%)

$14,667,000 (2.80%)

HCSG Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

13.30% (3.91%)

12.80% (11.30%)

11.50% (-16.67%)

13.80% (-9.21%)

Profit Margin

2.30% (0.00%)

2.30% (15.00%)

2.00% (-28.57%)

2.80% (-50.00%)

EBITDA Margin

4.30% (-4.44%)

4.50% (18.42%)

3.80% (-19.15%)

4.70% (-42.68%)

Return on Average Equity (ROAE)

8.20% (-4.65%)

8.60% (7.50%)

8.00% (-16.67%)

9.60% (-55.35%)

Return on Average Assets (ROAA)

4.90% (-3.92%)

5.10% (8.51%)

4.70% (-18.97%)

5.80% (-55.73%)

Return on Sales (ROS)

3.50% (-2.78%)

3.60% (28.57%)

2.80% (-26.32%)

3.80% (-48.65%)

Return on Invested Capital (ROIC)

11.80% (-4.84%)

12.40% (18.10%)

10.50% (-23.91%)

13.80% (-53.06%)

Dividend Yield

0% (0%)

0% (0%)

7.10% (51.06%)

4.70% (62.07%)

Price to Earnings Ratio (P/E)

21.51 (7.86%)

19.94 (-21.89%)

25.53 (-12.45%)

29.16 (37.00%)

Price to Sales Ratio (P/S)

0.5 (8.24%)

0.46 (-12.69%)

0.53 (-34.90%)

0.81 (-31.96%)

Price to Book Ratio (P/B)

1.7 (1.55%)

1.68 (-19.61%)

2.09 (-28.78%)

2.93 (-32.71%)

Debt to Equity Ratio (D/E)

0.61 (-17.21%)

0.73 (6.71%)

0.69 (-4.46%)

0.72 (13.25%)

Earnings Per Share (EPS)

0.54 (3.85%)

0.52 (10.64%)

0.47 (-22.95%)

0.61 (-53.79%)

Sales Per Share (SPS)

23.26 (3.39%)

22.5 (-1.05%)

22.74 (3.60%)

21.95 (-6.87%)

Free Cash Flow Per Share (FCFPS)

0.34 (-34.82%)

0.51 (393.71%)

-0.17 (-141.37%)

0.42 (-85.18%)

Book Value Per Share (BVPS)

6.78 (10.27%)

6.15 (7.22%)

5.73 (-5.26%)

6.05 (-5.92%)

Tangible Assets Book Value Per Share (TABVPS)

9.73 (2.84%)

9.46 (12.21%)

8.43 (-7.48%)

9.12 (-4.87%)

Enterprise Value Over EBIT (EV/EBIT)

14 (7.69%)

13 (-31.58%)

19 (-5.00%)

20 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

11.59 (10.23%)

10.51 (-26.22%)

14.25 (-11.81%)

16.16 (17.41%)

Asset Turnover

2.14 (-3.44%)

2.21 (-4.24%)

2.31 (11.54%)

2.07 (-11.53%)

Current Ratio

2.89 (9.72%)

2.63 (-7.48%)

2.85 (-0.38%)

2.86 (-18.96%)

Dividends

$0 (0%)

$0 (0%)

$0.85 (2.40%)

$0.83 (2.59%)

Free Cash Flow (FCF)

$24,677,000 (-35.42%)

$38,213,000 (394.31%)

-$12,984,000 (-141.05%)

$31,632,000 (-85.16%)

Enterprise Value (EV)

$857,165,627 (8.34%)

$791,146,130 (-12.40%)

$903,171,000 (-28.22%)

$1,258,264,810 (-36.87%)

Earnings Before Tax (EBT)

$52,941,000 (-0.22%)

$53,056,000 (17.69%)

$45,082,000 (-27.08%)

$61,823,000 (-52.14%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$73,964,000 (-1.72%)

$75,256,000 (18.73%)

$63,385,000 (-18.61%)

$77,875,000 (-46.23%)

Invested Capital

$473,156,000 (1.11%)

$467,973,000 (2.84%)

$455,058,000 (5.50%)

$431,349,000 (1.37%)

Working Capital

$364,105,000 (2.63%)

$354,768,000 (7.50%)

$330,013,000 (-7.11%)

$355,257,000 (-13.38%)

Tangible Asset Value

$717,801,000 (2.11%)

$702,996,000 (12.15%)

$626,859,000 (-8.08%)

$681,969,000 (-4.72%)

Market Capitalization

$851,275,627 (11.16%)

$765,814,130 (-13.86%)

$889,056,000 (-32.95%)

$1,326,048,810 (-36.59%)

Average Equity

$483,669,750 (8.11%)

$447,377,500 (3.28%)

$433,182,500 (-9.48%)

$478,572,000 (4.43%)

Average Assets

$803,048,750 (6.28%)

$755,564,750 (3.25%)

$731,768,000 (-7.72%)

$792,983,750 (5.45%)

Invested Capital Average

$505,297,000 (2.70%)

$491,993,250 (7.42%)

$458,005,250 (0.30%)

$456,647,500 (2.74%)

Shares

73,291,057 (-0.76%)

73,849,000 (-0.32%)

74,088,000 (-0.61%)

74,539,000 (0.15%)